TCM
WST icon

Teza Capital Management’s West Pharmaceutical WST Stock Holding History

Teza Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,253
Closed -$441K – 765
2023
Q4 		$441K Buy
+1,253
New +$443K 0.07% 325
2022
Q4 		– Sell
-1,509
Closed -$371K – 742
2022
Q3 		$371K Buy
+1,509
New +$460K 0.08% 358
2022
Q1 		– Sell
-1,002
Closed -$470K – 560
2021
Q4 		$470K Buy
+1,002
New +$431K 0.13% 221

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Teza Capital Management's WST Position: Q1 2024 in Review

Teza Capital Management sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 1,253 shares — an estimated $441K sold.

Teza Capital Management first reported a position in WST in Q4 2021 and held it in 3 quarters. The position peaked at $470K in Q4 2021. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Teza Capital Management reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Teza Capital Management sold 1,253 West Pharmaceutical shares in Q1 2024, an estimated $441K.
  • Teza Capital Management first reported a position in West Pharmaceutical in Q4 2021 and held it in 3 quarters.
  • Teza Capital Management's West Pharmaceutical position peaked at $470K in Q4 2021.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Teza Capital Management's 13F filing for Q1 2024, filed 15 May 2024.